Pediatric oncology is the diagnosis, treatment, and research of cancer in children and adolescents. The session "Pediatric Oncology" emphasizes the special challenges and progress in treating cancers in children, which frequently have significantly different biology and responsiveness to therapy than adult cancers.
Common childhood cancers are leukemia, brain tumors, neuroblastoma, and sarcomas. Treatment can blend surgery, chemotherapy, radiation, and increasingly, targeted agents and immunotherapies specifically designed for children. Particular care is taken to avoid long-term side effects, promote growth and development, and enhance the quality of life.
This session also discusses novel research and clinical trials to find new treatments for childhood cancers. Genomics and molecular profiling advancements are enabling clinicians to determine individual mutations and weaknesses in the tumor, so more personalized and effective treatment is possible. Supportive care, such as psychological and social support for patients and families, is an essential component of pediatric oncology.
Participants will have a better understanding of the most recent strategies, challenges, and breakthroughs in the management of cancers in children. This session highlights the need for specialized treatment, research-based care, and multidisciplinary care to enhance survival rates and the best outcome possible for children with cancer."
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
